GlassScriptPhysician profile
Varsha D Allampalli
NPI 1609233030
$2,502.86
in general payments reported to CMS, 2019-2025
9 companies · $1,255 in 2025
The $1,255 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $128 · 2023: $274 · 2024: $846 · 2025: $1,255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,214 · Travel and Lodging: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,213.98 |
| Travel and Lodging | $1,161.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,214.18 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept, Artisan |
| Stryker Corporation | $943.92 | 2025 | Spinejack, Optablate, Mild Device Kit |
| Medtronic, INC. | $147.50 | 2024 | Intellis Adaptivestim |
| Abbott Laboratories | $68.24 | 2025 | Eterna |
| Averitas Pharma INC. | $36.31 | 2023 | Qutenza |
| Teleflex LLC | $33.00 | 2025 | Arrow |
| Saluda Medical Americas, INC. | $24.99 | 2023 | Evoke Scs |
| Fisher & Paykel Healthcare INC | $18.55 | 2025 | Fisher & Paykel Healthcare |
| Merck Sharp & Dohme LLC | $16.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varsha Allampalli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.